# Prelude Therapeutics Inc: Form 8-K, filed Mar 8, 2021

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2021-03-08
- Accepted by EDGAR: Mar 8, 2021, 16:09 ET
- Period: 2021-03-02
- Accession: 0001193125-21-073187
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312521073187/d152125d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312521073187/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312521073187/d152125d8k.htm

Filed Mar 8, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-073187. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
